{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:40:07Z","timestamp":1788212407689,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Regional Health Agency of Reunion Island"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"DOI":"10.1186\/s12245-025-01055-3","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:14:31Z","timestamp":1766150071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and toxicological epidemiology of intoxications by new psychoactive substances in Reunion Island"],"prefix":"10.1186","volume":"18","author":[{"given":"Adrien","family":"Maillot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Guyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeva","family":"Ma-Tsi-Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Berly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Weisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gael Le","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Nativel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Daveluy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9r\u00e9nice","family":"Puech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Marteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Pl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"1055_CR1","doi-asserted-by":"publisher","first-page":"101991","DOI":"10.1016\/j.jsps.2024.101991","volume":"32","author":"X Hou","year":"2024","unstructured":"Hou X, Wang J, Zhang Y, Zhang Y, Shangguan J, Qin G, et al. Exploring the topic structure and abuse trends of new psychoactive substance since the 21st century from a bibliometric perspective. Saudi Pharm J. 2024;32:101991. https:\/\/doi.org\/10.1016\/j.jsps.2024.101991.","journal-title":"Saudi Pharm J"},{"key":"1055_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/dta.319","volume":"3","author":"LA King","year":"2011","unstructured":"King LA, Kicman AT. A brief history of \u2018new psychoactive substances\u2019. Drug Test Anal. 2011;3:401\u20133. https:\/\/doi.org\/10.1002\/dta.319.","journal-title":"Drug Test Anal"},{"key":"1055_CR3","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2015.14043","author":"M Liechti","year":"2015","unstructured":"Liechti M. Novel psychoactive substances (designer drugs): overview and Pharmacology of modulators of monoamine signaling. Swiss Med Wkly. 2015. https:\/\/doi.org\/10.4414\/smw.2015.14043.","journal-title":"Swiss Med Wkly"},{"key":"1055_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/add.13528","volume":"112","author":"M Evans-Brown","year":"2017","unstructured":"Evans-Brown M, Sedefov R. New psychoactive substances: driving greater complexity into the drug problem. Addiction. 2017;112:36\u20138. https:\/\/doi.org\/10.1111\/add.13528.","journal-title":"Addiction"},{"key":"1055_CR5","volume-title":"European drug report 2024","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2024","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European drug report 2024. LU: Publications Office; 2024."},{"key":"1055_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/brainsci8070123","volume":"8","author":"C Miliano","year":"2018","unstructured":"Miliano C, Margiani G, Fattore L, De Luca M. Sales and advertising channels of new psychoactive substances (NPS): Internet, social Networks, and smartphone apps. Brain Sci. 2018;8:123. https:\/\/doi.org\/10.3390\/brainsci8070123.","journal-title":"Brain Sci"},{"key":"1055_CR7","unstructured":"Observatoire Fran\u00e7ais des Drogues et des Toxicomanies. Nouveaux produits de synth\u00e8se - Dix ans de recul sur la situation fran\u00e7aise. 2018."},{"key":"1055_CR8","doi-asserted-by":"publisher","first-page":"103396","DOI":"10.1016\/j.drugpo.2021.103396","volume":"98","author":"S Darke","year":"2021","unstructured":"Darke S, Banister S, Farrell M, Duflou J, Lappin J. Synthetic cannabis\u2019: A dangerous misnomer. Int J Drug Policy. 2021;98:103396. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103396.","journal-title":"Int J Drug Policy"},{"key":"1055_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/JCP.0000000000000882","volume":"38","author":"R Torrents","year":"2018","unstructured":"Torrents R, Ferr\u00e9 JF, Konareff A, Hemery P, Sherwin K, Lassalle C, et al. Misuse of trihexyphenidyl (Artane) on R\u00e9union Island. J Clin Psychopharmacol. 2018;38:250\u20133. https:\/\/doi.org\/10.1097\/JCP.0000000000000882.","journal-title":"J Clin Psychopharmacol"},{"key":"1055_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.therap.2018.01.007","volume":"73","author":"A Daveluy","year":"2018","unstructured":"Daveluy A, Haramburu F. Consommation de substances psychoactives \u00e0 La R\u00e9union et \u00e0 Mayotte, d\u00e9partements fran\u00e7ais de l\u2019Oc\u00e9an. Indien Ther. 2018;73:419\u201327. https:\/\/doi.org\/10.1016\/j.therap.2018.01.007.","journal-title":"Indien Ther"},{"key":"1055_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.toxac.2014.12.002","volume":"27","author":"O Roussel","year":"2015","unstructured":"Roussel O, Carlin MG, Bouvot X, Tensorer L. The emergence of synthetic cannabinoids in Mayotte. Toxicol Anal Clin. 2015;27:18\u201322. https:\/\/doi.org\/10.1016\/j.toxac.2014.12.002.","journal-title":"Toxicol Anal Clin"},{"key":"1055_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.toxac.2020.10.077","volume":"33","author":"R Goncalves","year":"2021","unstructured":"Goncalves R, M\u00e9t\u00e9 D, Maillot A, Peyr\u00e9 A, Bastard S, Youssouf A, et al. Importance de La consommation de \u00ab chimique \u00bb Dans les d\u00e9partements fran\u00e7ais de l\u2019Oc\u00e9an Indien. Toxicol Anal Clin. 2021;33:36. https:\/\/doi.org\/10.1016\/j.toxac.2020.10.077.","journal-title":"Toxicol Anal Clin"},{"key":"1055_CR13","doi-asserted-by":"publisher","unstructured":"Guyon J, Maillot A, Bastard S, Weisse F, Daveluy A, M\u00e9t\u00e9 D. Psychoactive cocktail consumption on reunion island: a case report. J Anal Toxicol 2025:bkaf009. https:\/\/doi.org\/10.1093\/jat\/bkaf009","DOI":"10.1093\/jat\/bkaf009"},{"key":"1055_CR14","volume-title":"Les comportements addictifs \u00e0 La R\u00e9union. Tableau de Bord","author":"M Ricquebourg","year":"2022","unstructured":"Ricquebourg M. Les comportements addictifs \u00e0 La R\u00e9union. Tableau de Bord. St-Denis: ORS La R\u00e9union; 2022."},{"key":"1055_CR15","doi-asserted-by":"publisher","first-page":"10577","DOI":"10.26355\/eurrev_201912_19753","volume":"23","author":"FP Busard\u00f2","year":"2019","unstructured":"Busard\u00f2 FP, Var\u00ec MR, di Trana A, Malaca S, Carlier J, di Luca NM. Drug-facilitated sexual assaults (DFSA): a serious underestimated issue. Eur Rev Med Pharmacol Sci. 2019;23:10577\u201387. https:\/\/doi.org\/10.26355\/eurrev_201912_19753.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1055_CR16","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.toxac.2023.08.090","volume":"35","author":"L Dufayet","year":"2023","unstructured":"Dufayet L, Liautard M, Douaouria S, Houz\u00e9 P, Labat L. Substances impliqu\u00e9es Dans les suspicions de soumission chimique: \u00e9tude prospective monocentrique \u2013 \u00e9tude TANCS (Toxicological analysis in chemical Submission). Toxicol Anal Clin. 2023;35:S115\u20136. https:\/\/doi.org\/10.1016\/j.toxac.2023.08.090.","journal-title":"Toxicol Anal Clin"},{"key":"1055_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.therap.2018.09.062","volume":"73","author":"A Daveluy","year":"2018","unstructured":"Daveluy A, Perri-Pland\u00e9 J, Baumevieille M, Peyr\u00e9 A, Miremont-Salam\u00e9 G. Addictovigilance Dans les d\u00e9partements d\u2019Outre-Mer. Therapies. 2018;73:565. https:\/\/doi.org\/10.1016\/j.therap.2018.09.062.","journal-title":"Therapies"},{"key":"1055_CR18","unstructured":"Auzole E. Substances psychoactives, usagers et march\u00e9s. Tendances r\u00e9centes Sur l\u2019\u00cele de La R\u00e9union En 2023. OFDT; 2024."},{"key":"1055_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00204-020-02693-7","volume":"94","author":"D Luethi","year":"2020","unstructured":"Luethi D, Liechti ME. Designer drugs: mechanism of action and adverse effects. Arch Toxicol. 2020;94:1085\u2013133. https:\/\/doi.org\/10.1007\/s00204-020-02693-7.","journal-title":"Arch Toxicol"},{"key":"1055_CR20","unstructured":"United Nations Office on Drugs and Crime. World drug report 2024. United Nations publication; 2024."},{"key":"1055_CR21","doi-asserted-by":"publisher","first-page":"112116","DOI":"10.1016\/j.forsciint.2024.112116","volume":"361","author":"HS Leung","year":"2024","unstructured":"Leung HS, Tang MHY, Tong HF, Chong YK. N,N-dimethylpentylone poisoning: clinical manifestations, analytical detection, and metabolic characterization. Forensic Sci Int. 2024;361:112116. https:\/\/doi.org\/10.1016\/j.forsciint.2024.112116.","journal-title":"Forensic Sci Int"},{"key":"1055_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12012-024-09832-x","volume":"24","author":"KL Groenewegen","year":"2024","unstructured":"Groenewegen KL, Gresnigt FMJ, Lonkhuyzen JJN, den Haan C, Franssen EJF, Riezebos RK, et al. Cardiotoxicity after synthetic Cathinone use; two cases, a case series and scoping review. Cardiovasc Toxicol. 2024;24:209\u201324. https:\/\/doi.org\/10.1007\/s12012-024-09832-x.","journal-title":"Cardiovasc Toxicol"},{"key":"1055_CR23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/jat\/bkaa159","volume":"45","author":"E Domagalska","year":"2021","unstructured":"Domagalska E, Banaszkiewicz L, Wo\u017aniak MK, Kata M, Szpiech B, Kaliszan M. Fatal N-Ethylhexedrone intoxication. J Anal Toxicol. 2021;45:e1\u20136. https:\/\/doi.org\/10.1093\/jat\/bkaa159.","journal-title":"J Anal Toxicol"},{"key":"1055_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10408444.2020.1762539","volume":"50","author":"VL Alves","year":"2020","unstructured":"Alves VL, Gon\u00e7alves JL, Aguiar J, Teixeira HM, C\u00e2mara JS. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review. Crit Rev Toxicol. 2020;50:359\u201382. https:\/\/doi.org\/10.1080\/10408444.2020.1762539.","journal-title":"Crit Rev Toxicol"},{"key":"1055_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/15563650.2021.1994144","volume":"60","author":"R Goncalves","year":"2022","unstructured":"Goncalves R, Labadie M, Chouraqui S, Peyr\u00e9 A, Castaing N, Daveluy A, et al. Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings. Clin Toxicol. 2022;60:458\u201363. https:\/\/doi.org\/10.1080\/15563650.2021.1994144.","journal-title":"Clin Toxicol"},{"key":"1055_CR26","doi-asserted-by":"publisher","first-page":"103493","DOI":"10.1016\/j.drugpo.2021.103493","volume":"100","author":"PE Oomen","year":"2022","unstructured":"Oomen PE, Schori D, T\u00f6gel-Lins K, Acreman D, Chenorhokian S, Luf A, et al. Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services. Int J Drug Policy. 2022;100:103493. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103493.","journal-title":"Int J Drug Policy"},{"key":"1055_CR27","doi-asserted-by":"publisher","DOI":"10.1089\/can.2023.0154","author":"J Guyon","year":"2023","unstructured":"Guyon J, Paradis C, Titier K, Braganca C, Peyre A, Nardon A, et al. Letter to the Editor: the cannabinoid consumed is not necessarily the one expected: recent experience with hexahydrocannabinol. Cannabis Cannabinoid Res. 2023. https:\/\/doi.org\/10.1089\/can.2023.0154. can.2023.0154.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1055_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-025-04102-3","author":"C Caprari","year":"2025","unstructured":"Caprari C, Ferri E, Rossetti P, Gregori A, Citti C, Cannazza G. The emergence of nitazenes: a new chapter in the synthetic opioid crisis. Arch Toxicol. 2025. https:\/\/doi.org\/10.1007\/s00204-025-04102-3.","journal-title":"Arch Toxicol"},{"key":"1055_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/brainsci8090170","volume":"8","author":"P Frisoni","year":"2018","unstructured":"Frisoni P, Bacchio E, Bilel S, Talarico A, Gaudio RM, Barbieri M, et al. Novel synthetic opioids: the pathologist\u2019s point of view. Brain Sci. 2018;8:170. https:\/\/doi.org\/10.3390\/brainsci8090170.","journal-title":"Brain Sci"},{"key":"1055_CR30","doi-asserted-by":"publisher","first-page":"108019","DOI":"10.1016\/j.pharmthera.2021.108019","volume":"233","author":"P Skolnick","year":"2022","unstructured":"Skolnick P. Treatment of overdose in the synthetic opioid era. Pharmacol Ther. 2022;233:108019. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108019.","journal-title":"Pharmacol Ther"},{"key":"1055_CR31","unstructured":"World Health Organization. Critical review report: protonitazene. 2022."},{"key":"1055_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","volume":"134","author":"P Armenian","year":"2018","unstructured":"Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, Fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology. 2018;134:121\u201332. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.016.","journal-title":"Neuropharmacology"},{"key":"1055_CR33","doi-asserted-by":"publisher","unstructured":"Negrault N, Puech B, Guyon J, Daveluy A, Bastard S, Mete D et al. Case series of severe intoxications associated with new psychoactive substances on reunion island: clinical description and diagnostic challenges. Toxicol Anal Clin 2025:S2352007825000964. https:\/\/doi.org\/10.1016\/j.toxac.2025.01.096","DOI":"10.1016\/j.toxac.2025.01.096"},{"key":"1055_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fpsyt.2017.00236","volume":"8","author":"N Pinterova","year":"2017","unstructured":"Pinterova N, Horsley RR, Palenicek T, Synthetic Aminoindanes. A summary of existing knowledge. Front Psychiatry. 2017;8:236. https:\/\/doi.org\/10.3389\/fpsyt.2017.00236.","journal-title":"Front Psychiatry"},{"key":"1055_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jpba.2018.10.011","volume":"163","author":"S Graziano","year":"2019","unstructured":"Graziano S, Anzillotti L, Mannocchi G, Pichini S, Busard\u00f2 FP. Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices. J Pharm Biomed Anal. 2019;163:170\u20139. https:\/\/doi.org\/10.1016\/j.jpba.2018.10.011.","journal-title":"J Pharm Biomed Anal"},{"key":"1055_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11306-022-01963-y","volume":"18","author":"NF De Jonge","year":"2022","unstructured":"De Jonge NF, Mildau K, Meijer D, Louwen JJR, Bueschl C, Huber F, et al. Good practices and recommendations for using and benchmarking computational metabolomics metabolite annotation tools. Metabolomics. 2022;18:103. https:\/\/doi.org\/10.1007\/s11306-022-01963-y.","journal-title":"Metabolomics"},{"key":"1055_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00213-022-06292-5","volume":"240","author":"SE Walton","year":"2023","unstructured":"Walton SE, Krotulski AJ, Glatfelter GC, Walther D, Logan BK, Baumann MH. Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats. Psychopharmacology. 2023;240:185\u201398. https:\/\/doi.org\/10.1007\/s00213-022-06292-5.","journal-title":"Psychopharmacology"},{"key":"1055_CR38","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00204-024-03774-7","volume":"98","author":"LM De Vrieze","year":"2024","unstructured":"De Vrieze LM, Walton SE, Pottie E, Papsun D, Logan BK, Krotulski AJ, et al. In vitro structure\u2013activity relationships and forensic case series of emerging 2-benzylbenzimidazole \u2018nitazene\u2019 opioids. Arch Toxicol. 2024;98:2999\u20133018. https:\/\/doi.org\/10.1007\/s00204-024-03774-7.","journal-title":"Arch Toxicol"},{"key":"1055_CR39","unstructured":"Obradovic I. Drogues et addictions Dans les Outre-mer. \u00c9tat des Lieux et probl\u00e9matiques. OFDT; 2020."},{"key":"1055_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.therap.2024.10.056","volume":"80","author":"A Daveluy","year":"2025","unstructured":"Daveluy A, Perino J, Gibaja V, Le Boisselier R, Batisse A, Miremont-Salam\u00e9 G, et al. From regional signal to alert in addictovigilance. Therapies. 2025;80:213\u201322. https:\/\/doi.org\/10.1016\/j.therap.2024.10.056.","journal-title":"Therapies"},{"key":"1055_CR41","unstructured":"Maillot A, M\u00e9t\u00e9 D. Campagne de sensibilisation aux cannabino\u00efdes de synth\u00e8se \u00e0 La R\u00e9union: \u00e9valuation et perspectives. Alcoologie et addictologie 2025. Addictologie Et Douleur : 14\u201320."}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-025-01055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-025-01055-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-025-01055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:14:33Z","timestamp":1766150073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12245-025-01055-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1186\/s12245-025-01055-3","relation":{},"ISSN":["1865-1380"],"issn-type":[{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by CNIL (n\u00b0921274, February 2022) and an institutional review board (AP 2022-19). Patient non-opposition was obtained with an information leaflet. All cases were reported to the French Addictovigilance Network in accordance with legal requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}